Evidence map›Paper›PMID 34615821›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric Cancer.

Yoko Taminishi-Katsuragawa, Yuji Shimura, Yu Inoue, Yayoi Matsumura-Kimoto, Taku Tsukamoto, Shinsuke Mizutani, Tsutomu Kobayashi, Naoko Takeda-Miyata, Ayako Nishimura, Kojiro Takatsuka and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yoko Taminishi-KatsuragawaDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Yuji ShimuraDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Yu InoueDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Yayoi Matsumura-KimotoDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Taku TsukamotoDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Shinsuke MizutaniDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Tsutomu KobayashiDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Naoko Takeda-MiyataDepartment of Surgical Pathology, Kyoto Prefectural University of Medicine, Japan.
Ayako NishimuraDepartment of Surgical Pathology, Kyoto Prefectural University of Medicine, Japan.
Kojiro TakatsukaMaiduru Kyoritsu Clinic, Japan.
Junya KurodaDivision of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Kyoto Prefectural University of Medicine · JPHiroshima Kyoritsu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcoma (MS) is a relatively rare manifestation of myeloid neoplasms at sites other than the bone marrow. The rarity of gastrointestinal (GI) MS is attributed to certain factors, such as misdetection due to insufficient endoscopic assessments at the initial presentation with acute myeloid leukemia (AML) as well as the difficulty of making a histologic assessment of leukemic involvement of the GI tract. We herein report a case of AML with gastric involvement and discuss the importance of screening examinations and therapies considering the location of MS and the data of cytogenetic and molecular mutation.

Indexed as

Leukemia, Myeloid, AcuteSarcoma, MyeloidStomach NeoplasmsBone MarrowHumansMutationgastrointestinal myeloid sarcomamyeloid sarcomaNPM1 mutation

Identifiers

PMID34615821
PMCPMC9107997
OpenAlexW3204611275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.